Mankind Pharma Ltd - MANKIND PHARMA Share Price

Sector: Pharmaceuticals | ISIN:
₹ 2,154.05 (-1.61%) icon23 Feb, 2024, 12:00:00 AM

Mankind Pharma Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/23/2024 12:00:00 AM

    ₹ 2154.05 -35.15 -1.61
  • Open
  • ₹ 2,212
  • Prev. Close
  • ₹ 2,189.2
  • Turnover(Lac.)
  • ₹ 5,652
  • Day's High
  • ₹ 2,215
  • Day's Low
  • ₹ 2,148
  • 52 Week's High
  • ₹ 2,297.4
  • 52 Week's Low
  • ₹ 1,242
  • Book Value
  • ₹ 228.49
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 86,288.75
  • P/E
  • 52.27
  • EPS
  • 41.2
  • Divi. Yield
  • 0

Mankind Pharma Ltd Corporate Actions

16 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

16 Jan , 2024

12:00 AM

11 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 Oct , 2023

12:00 AM

24 Aug , 2023

12:00 AM

AGM

Announcement date: 24 Aug , 2023

View Details

18 Jul , 2023

12:00 AM

18 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

22 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

Mankind Pharma Ltd News and Update

Image not found
  • 23 February, 2024 |
  • 12:07 AM

Under the "ILS Hospitals" brand, GPT Healthcare Ltd. manages a network of mid-sized full-service hospitals that offer integrated healthcare services, with an emphasis on secondary and tertiary care.

Image not found
  • IIFL News Service |
  • 22 February, 2024 |
  • 12:06 AM
Image not found
  • IIFL News Service |
  • 22 February, 2024 |
  • 12:06 AM
Image not found
  • IIFL News Service |
  • 19 February, 2024 |
  • 12:02 AM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Mankind Pharma Ltd SHAREHOLDING SNAPSHOT
26 February , 2024 | 02:54 AM

PROMOTER - TOTAL76.50%

Indian: 76.50%

Foreign: 0%

NON-PROMOTER - TOTAL 23.50%

Institutions: 16.53%

Non-Institutions: 6.97%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Mankind Pharma Ltd FINANCIALS

No Data Available To Display Chart

Mankind Pharma Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Mankind Pharma Ltd

  • RAMESH CHAND JUNEJA
  • Chairman & Wholetime Director
  • RAJEEV JUNEJA
  • Vice Chairman & M.D.
  • SHEETAL ARORA
  • Whole Time Director & CEO
  • TILOKCHAND PUNAMCHAND OSTWAL
  • Independent Director
  • Pradeep Chugh
  • Company Sec. & Compli. Officer
  • Bharat Anand
  • Independent Director
  • SATISH KUMAR SHARMA
  • Whole-time Director
  • Vivek Kalra
  • Independent Director
  • Vijaya Sampath
  • Independent Director

Summary

Mankind Pharma Ltd. was incorporated on July 3, 1991, as a Private Limited Company with the name Mankind Pharma Private Limited, by the Registrar of Companies, Delhi and Haryana, at New Delhi. Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to Mankind Pharma Limited and the RoC issued a fresh Certificate of Incorporation on April 13, 2006.The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products. It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory. In 2004, the Company entered the chronic pharmaceutical segment with the launch of Amlokind tablets and Glimestar tablets amongst others. It set up their first manufacturing facility at Paonta Sahib, in Himachal Pradesh during year 2005. It entered the ophthalmic pharmaceutical segment with the launching of Lubistar Eye Drops and Tobastar Eye Drops. In 2007, the Company entered the consumer healthcare segment with the launch of Manforce brand and have since established several differentiated brands in condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineralsupplements and anti-acne preparations categories. It entered into the business of animal... Read More


Reports by Mankind Pharma Ltd


Reports by Mankind Pharma Ltd

Company FAQ

No Record Found